Utility of a Monoclonal ERG/FLI1 Antibody for Immunohistochemical Discrimination of Ewing's Family Tumors

被引：0
|
作者：
Tomlins, S. A. [1 ]
Palanisamy, N. [1 ]
Brenner, J. C. [1 ]
Stall, J. N. [1 ]
Thomas, D. G. [1 ]
Siddiqui, J. [1 ]
Lucas, D. R. [1 ]
Chinnaiyan, A. M. [1 ]
Kunju, L. P. [1 ]
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
76
引用
收藏
页码：21A / 21A
页数：1
相关论文
共 50 条
  • [31] Pharmaceutical means of targeting the fusion oncogene EWS-FLI1 in the Ewing family of tumors
    Heisey, Daniel A.
    Lochmann, Timothy
    Calbert, Marissa
    Ghotra, Maninderjit
    Maves, Yuki Kato
    Boikos, Sosipatros
    Benes, Cyril
    Reynolds, C. Patrick
    Faber, Anthony
    CANCER RESEARCH, 2019, 79 (13)
  • [32] The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors
    Mendiola, M
    Carrillo, J
    García, E
    Lalli, E
    Hernández, T
    de Alava, E
    Tirode, F
    Delattre, O
    Garcia-Miguel, P
    López-Barea, F
    Pestaña, A
    Alonso, J
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (06) : 1381 - 1389
  • [33] Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma
    Rao, Donald D.
    Jay, Christopher
    Wang, Zhaohui
    Luo, Xiuquan
    Kumar, Padmasini
    Eysenbach, Hilary
    Ghisoli, Maurizio
    Senzer, Neil
    Nemunaitis, John
    MOLECULAR THERAPY, 2016, 24 (08) : 1412 - 1422
  • [34] IMMUNOHISTOCHEMICAL STAINING OF PEDIATRIC TUMORS WITH THE MONOCLONAL ANTIBODY-MB2 - A POTENTIAL MARKER FOR EWING SARCOMA
    THORNER, PS
    KAHN, HJ
    MODERN PATHOLOGY, 1988, 1 (01) : A93 - A93
  • [35] HIF-1\#945; mediates hypoxia modulation of EWS-FLI1 expression in Ewing\#8217;s sarcoma family tumors
    Aryee, Dave
    Niedan, Stephan
    Muehlbacher, Karin
    Kauer, Max
    Ban, Jozef
    Bennani-Baiti, Idriss
    Kovar, Heinrich
    CANCER RESEARCH, 2009, 69
  • [36] The dual inhibitory effect of thiostrepton on FoxM1 and EWS/FLI1 provides a novel therapeutic option for Ewing's sarcoma
    Sengupta, Aniruddha
    Rahman, Mahbubur
    Mateo-Lozano, Silvia
    Tirado, Oscar M.
    Notario, Vicente
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (03) : 803 - 812
  • [37] Assessing EWS/FLI1 activity as a read-out for small-molecule drug screening in Ewing's sarcoma
    Rechfeld, Florian
    Boro, Aleksandar
    Niggli, Felix K.
    Schaefer, Beat W.
    CANCER RESEARCH, 2011, 71
  • [38] Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing Family Tumors
    Li, Yan
    Li, Xu
    Fan, Guangyu
    Fukushi, Jun-ichi
    Matsumoto, Yoshihiro
    Iwamoto, Yukihide
    Zhu, Yue
    CANCER LETTERS, 2012, 320 (01) : 14 - 22
  • [39] Ewing's Sarcoma Family Tumors in the Jaws: Case Report, Immunohistochemical Analysis and Literature Review
    Casaroto, Ana Regina
    Da Silva Sampieri, Marcelo Bonifacio
    Soares, Cleverson Teixeira
    Da Silva Santos, Paulo Sergio
    Faria Yaedu, Renato Yassutaka
    Damante, Jose Humberto
    Lara, Vanessa Soares
    IN VIVO, 2017, 31 (03): : 481 - 491
  • [40] Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma
    Boro, Aleksandar
    Pretre, Kathya
    Rechfeld, Florian
    Thalhammer, Verena
    Oesch, Susanne
    Wachtel, Marco
    Schaefer, Beat W.
    Niggli, Felix K.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (09) : 2153 - 2164
12345